Related Experiment Video
Updated: Aug 15, 2025

10:07
Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
66.7K
In Vitro Methods to Evaluate Macrophage Polarization and Function in Cancer
Aldo Ummarino1,2, Clément Anfray3, Akihiro Maeda1
1Department of Immunology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy.
Methods in Molecular Biology (Clifton, N.J.)
|December 31, 2022
Summary
Tumor-associated macrophages (TAMs) suppress anti-cancer immunity. This study details in vitro methods to reprogram TAMs into anti-tumor effector cells, offering new therapeutic strategies.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Therapeutics
Background:
- Tumor-associated macrophages (TAMs) exhibit immunosuppressive functions, hindering cancer immunity and treatment efficacy.
- Macrophage plasticity presents a therapeutic target for reprogramming towards anti-tumor phenotypes.
- Understanding TAM polarization is crucial for developing novel cancer therapies.
Purpose of the Study:
- To describe in vitro protocols for isolating and analyzing primary human monocytes and macrophages.
- To detail methods for assessing macrophage phenotype and function following exposure to novel therapies.
- To establish a protocol for evaluating the in vitro cytotoxic activity of treated macrophages against cancer cells.
Main Methods:
- Isolation of primary monocytes from buffy coats.
- Flow cytometry, RT-PCR, and ELISA for analyzing macrophage phenotype and function.
- In vitro assessment of cytotoxic activity of macrophages against cancer cells.
Main Results:
- Established protocols for monocyte isolation and macrophage differentiation.
- Demonstrated methods for evaluating therapeutic effects on macrophage polarization and function.
- Validated a system for assessing macrophage-mediated cancer cell killing.
Conclusions:
- The described in vitro protocols enable robust analysis of macrophage responses to therapeutic interventions.
- Reprogramming TAMs towards an M1-like phenotype is a viable strategy for enhancing anti-tumor immunity.
- These methodologies facilitate the development and validation of novel immunotherapies for cancer treatment.

